NLRC4 is a protein sensor that sits inside your cells and watches for signs of bacterial invasion. When certain disease-causing bacteria inject molecular machinery into a cell or swim in using whip-like flagella, NLRC4 detects those components and triggers an aggressive inflammatory response designed to kill both the bacteria and the infected cell. It belongs to a family of intracellular alarm systems called inflammasomes, and what makes NLRC4 stand out is its specificity: it responds to structural proteins that are hallmarks of dangerous, actively invading bacteria rather than the harmless microbes living peacefully in your gut.
How NLRC4 Spots Bacterial Intruders
NLRC4 does not actually detect bacteria on its own. It relies on a family of upstream sensor proteins called NAIPs (neuronal apoptosis inhibitory proteins) that do the initial recognition work. In mice, the system is well characterized: NAIP1 detects the needle protein of bacterial injection systems, NAIP2 recognizes the inner rod of those same systems, and NAIP5 and NAIP6 detect flagellin, the building block of bacterial flagella.1PubMed Central. Broad detection of bacterial type III secretion system and flagellin proteins by the human NAIP/NLRC4 inflammasome The injection systems these NAIPs detect are called type III secretion systems, and they are essentially molecular syringes that pathogenic bacteria like Salmonella and Pseudomonas use to pump toxins directly into your cells.
Humans have a simpler version of this setup. Instead of multiple specialized NAIPs, we have a single human NAIP that can recognize several of these bacterial components. The human version detects both type III secretion system proteins and flagellin, though the details of how one protein manages to sense such different molecular shapes are still being worked out.1PubMed Central. Broad detection of bacterial type III secretion system and flagellin proteins by the human NAIP/NLRC4 inflammasome What matters is that the system is tuned to catch bacteria in the act of doing something aggressive. A bacterium that is simply sitting in the gut is invisible to NLRC4, but one that fires up its injection machinery or assembles flagella to swim into tissue gets flagged immediately.
A Single Sensor Triggers a Chain Reaction
Once a NAIP protein grabs onto its bacterial target, it physically changes shape and binds to NLRC4. That initial pairing is just the start. The activated NAIP-NLRC4 pair then recruits additional NLRC4 molecules, which snap together into a large disc-shaped structure. Cryo-electron microscopy has revealed that this assembly works like a line of falling dominoes: a single activated NAIP is enough to trigger NLRC4 after NLRC4 to undergo a dramatic hinge rotation of roughly 90 degrees and lock into the growing disc.2PubMed Central. Cryo-EM structure of the activated NAIP2-NLRC4 inflammasome reveals nucleated polymerization Ligand binding to a NAIP is required before this co-assembly with NLRC4 can proceed, so the system has a built-in safety check: no bacterial signal, no disc formation.3PubMed Central. Molecular basis for specific recognition of bacterial ligands by NAIP/NLRC4 inflammasomes
This design is fundamentally different from some other molecular alarm platforms in the cell. In the related apoptosome, which triggers programmed cell death during development or DNA damage, every single subunit needs its own activation signal before the structure can assemble. NLRC4 takes a more aggressive approach: one confirmed bacterial signal, and the whole complex builds itself automatically.2PubMed Central. Cryo-EM structure of the activated NAIP2-NLRC4 inflammasome reveals nucleated polymerization The advantage of this domino design is speed. When a bacterium has breached the cell, there is no time to wait for multiple confirmation signals.
What Happens After the Alarm Fires
The assembled NLRC4 disc activates an enzyme called caspase-1, which then sets off two parallel responses. First, caspase-1 processes inflammatory signaling molecules, particularly IL-1β and IL-18, into their active forms. These cytokines rush out of the cell and recruit immune reinforcements, especially neutrophils, which are the front-line killers of bacterial infections. Second, caspase-1 cleaves a protein called gasdermin-D. Once cut, gasdermin-D fragments punch holes in the cell’s own membrane, creating large pores that cause the cell to swell and burst in a form of inflammatory cell death called pyroptosis.4PLOS Pathogens. Gasdermin-D and Caspase-7 are the key Caspase-1/8 substrates downstream of the NAIP5/NLRC4 inflammasome required for restriction of Legionella pneumophila
Pyroptosis is deliberately destructive. The infected cell dies, spilling its contents into the surrounding tissue, which amplifies inflammation and exposes any bacteria that were hiding inside the cell to other immune cells waiting outside. Gasdermin-D is essential for this pore-forming step; when it is blocked experimentally, the characteristic membrane rupture does not occur.5PLoS Pathogens. Inhibition of caspase-1 or gasdermin-D enable caspase-8 activation in the Naip5/NLRC4/ASC inflammasome Caspase-1 also activates caspase-7, another enzyme that contributes to restricting intracellular bacteria like Legionella, the cause of Legionnaires’ disease.4PLOS Pathogens. Gasdermin-D and Caspase-7 are the key Caspase-1/8 substrates downstream of the NAIP5/NLRC4 inflammasome required for restriction of Legionella pneumophila
A Backup Plan When the Main Pathway Fails
The immune system is not one to rely on a single mechanism. When researchers knocked out caspase-1 in macrophages and then activated NLRC4, the cells still died, but through an alternative route that looked more like apoptosis, a quieter, less inflammatory form of cell death. A genome-wide screen identified caspase-8 and the adaptor protein ASC as the key players in this backup pathway.6PubMed Central. ASC- and caspase-8-dependent apoptotic pathway diverges from the NLRC4 inflammasome in macrophages So even if a pathogen manages to disable caspase-1, NLRC4 can still kill the infected cell through a different route. This redundancy makes the NLRC4 system harder for bacteria to fully shut down.
One surprising finding from this work was that GSDME, another member of the gasdermin pore-forming family, turned out to be unnecessary for the secondary cell destruction that follows NLRC4-triggered apoptosis in macrophages.6PubMed Central. ASC- and caspase-8-dependent apoptotic pathway diverges from the NLRC4 inflammasome in macrophages The immune system appears to maintain multiple overlapping killing strategies downstream of NLRC4, ensuring that at least one pathway gets the job done even when individual components are compromised.
The Gut Has Its Own Strategy
NLRC4 plays a particularly striking role in the intestinal lining. The cells that line your gut, called intestinal epithelial cells, face constant exposure to bacteria. When Salmonella invades these cells, the NLRC4 inflammasome does not simply kill the infected cell and leave a hole in the barrier. Instead, it triggers a coordinated expulsion: the infected cell is physically ejected into the gut lumen, taking its bacterial passengers with it.7PubMed. Epithelium-intrinsic NAIP/NLRC4 inflammasome drives infected enterocyte expulsion to restrict Salmonella replication in the intestinal mucosa This expulsion is non-lytic, meaning the cell gets pushed out relatively intact rather than bursting open, which helps preserve the gut barrier even as infected cells are removed.8PubMed Central. NAIP-NLRC4 inflammasomes coordinate intestinal epithelial cell expulsion with eicosanoid and IL-18 release via activation of Caspase-1 and -8
When researchers deleted inflammasome components specifically in the gut epithelium of mice and then infected them with Salmonella, the results were dramatic. Without the ability to expel infected cells, bacterial loads inside the intestinal lining shot up roughly a hundredfold, and the bacteria spread much more rapidly to lymph nodes.7PubMed. Epithelium-intrinsic NAIP/NLRC4 inflammasome drives infected enterocyte expulsion to restrict Salmonella replication in the intestinal mucosa Activating NLRC4 selectively in epithelial cells was enough to trigger a full innate immune response including IL-18 release, fluid loss, and massive shedding of cells into the intestinal lumen, visible as blunted villi under the microscope.8PubMed Central. NAIP-NLRC4 inflammasomes coordinate intestinal epithelial cell expulsion with eicosanoid and IL-18 release via activation of Caspase-1 and -8
Telling Friend from Foe in the Intestine
One of the most impressive features of the NLRC4 system in the gut is its ability to distinguish between pathogenic and commensal bacteria. Your intestines harbor trillions of harmless microbes, and an immune sensor that attacked all of them would be catastrophic. NLRC4-driven production of IL-1β appears to be specifically tuned to respond to pathogenic bacteria while ignoring commensals. In mice, loss of NLRC4 or the receptor for IL-1 made them highly susceptible to oral Salmonella infection, with reduced neutrophil recruitment and impaired clearance of the pathogen from the gut.9PubMed Central. NLRC4-driven production of IL-1β discriminates between pathogenic and commensal bacteria and promotes host intestinal defense The same mice were not more vulnerable when bacteria were injected directly into the abdomen, suggesting that NLRC4 is specifically important at the mucosal surface where bacteria first make contact.
This selectivity makes biological sense. Commensal bacteria generally do not deploy type III secretion systems or swim aggressively into epithelial cells. By keying its detection to the molecular tools of invasion rather than to generic bacterial molecules, NLRC4 avoids friendly fire against the beneficial microbiome while still catching genuinely dangerous pathogens.
Lung Defense and Working with Other Sensors
NLRC4 is not limited to the gut. In the lungs, it collaborates with another bacterial sensor called TLR5 to defend against Pseudomonas aeruginosa, an opportunistic pathogen that causes severe pneumonia, especially in people with cystic fibrosis or weakened immune systems. Both TLR5 and NLRC4 can detect flagellin, but they work from different positions: TLR5 senses flagellin outside the cell, while NLRC4 catches it after bacteria have entered. Mice lacking either sensor alone handled Pseudomonas lung infection reasonably well, but mice missing both experienced a more than five-thousandfold increase in bacterial burden in the lungs, along with systemic bacterial spread and significantly higher death rates.10Journal of Innate Immunity. Redundant and Cooperative Interactions between TLR5 and NLRC4 in Protective Lung Mucosal Immunity against Pseudomonas aeruginosa
Levels of active IL-1β and IL-18 in the lung fluid dropped in mice lacking NLRC4 during Pseudomonas infection, confirming that NLRC4 is the primary driver of inflammasome-dependent cytokine production in this context, while TLR5 contributes through different downstream signals.10Journal of Innate Immunity. Redundant and Cooperative Interactions between TLR5 and NLRC4 in Protective Lung Mucosal Immunity against Pseudomonas aeruginosa The practical lesson is that mucosal surfaces like the lung and gut rely on layered, partially overlapping detection systems, and NLRC4 is a central node in that network.
How Bacteria Try to Hide from NLRC4
Given how effective NLRC4 detection can be, some bacteria have evolved strategies to dodge it. Salmonella enterica serovar Typhimurium, a major cause of food poisoning, uses a regulatory protein called SsrB to systematically shut down its own flagellar genes once it has invaded a host cell. Transcriptomic analysis showed that SsrB-dependent repression of motility genes led to fewer flagella per bacterial cell and reduced overall flagellin protein levels, making the bacterium less visible to the NAIP/NLRC4 system.11Cell Reports. SsrB Promotes the Evasion of Bacterial Motility Genes and Inflammasome Activation during Salmonella Infection
Interestingly, this stealth mechanism was specific to the human-adapted Salmonella. A closely related species, Salmonella bongori, actually increased its flagella production in response to the same regulatory protein, suggesting that the evasion strategy evolved specifically in the lineage that adapted to survive inside mammalian cells.11Cell Reports. SsrB Promotes the Evasion of Bacterial Motility Genes and Inflammasome Activation during Salmonella Infection This is a classic evolutionary arms race: the host builds a sensor, and the pathogen evolves a way to go quiet once it is inside.
When NLRC4 Misfires
A defense system this powerful can cause serious damage if it activates inappropriately. Several families have been identified with gain-of-function mutations in NLRC4, meaning the protein fires without a genuine bacterial signal. One mutation, a single amino acid change in the protein’s nucleotide-binding domain, caused a syndrome of neonatal-onset enterocolitis, periodic fevers, and life-threatening episodes of uncontrolled inflammation.12PubMed Central. Mutation of NLRC4 causes a syndrome of enterocolitis and autoinflammation A different mutation at a nearby position in the same domain caused recurrent macrophage activation syndrome, a condition in which the immune system’s scavenger cells go into overdrive, consuming blood cells and damaging organs. Patients with this mutation had extremely high levels of IL-18, exceeding even the levels seen in other well-known autoinflammatory conditions.13PubMed Central. An activating NLRC4 inflammasome mutation causes autoinflammation with recurrent macrophage activation syndrome
These diseases, collectively called NLRC4-associated autoinflammation, are rare but severe. They typically appear in infancy and can be fatal without treatment.14PubMed Central. An animal model of NLRC4-associated autoinflammation and infantile enterocolitis reveals novel therapeutic strategies The mutations cluster in the part of NLRC4 that normally keeps the protein in its inactive state, essentially breaking the safety latch. Without that restraint, the inflammasome assembles spontaneously, and the cell behaves as if it is under bacterial attack even when no pathogen is present.
Targeting IL-18 as Treatment
Because the runaway inflammation in NLRC4-mutant patients is driven by specific cytokines, blocking those cytokines offers a logical treatment strategy. Two patients with activating NLRC4 mutations and recurrent macrophage activation syndrome, one of whom also had intractable enterocolitis, were treated with recombinant human IL-18 binding protein (tadekinig alfa), which soaks up excess IL-18 before it can do damage. The results were striking: fevers stopped, blood markers of hyperinflammation normalized, the enterocolitis resolved, and the patients were able to come off other immunosuppressive medications and steroids.15PubMed Central. Life-threatening NLRC4-associated hyperinflammation successfully treated with IL-18 inhibition
This approach is more targeted than broadly suppressing the immune system with steroids or other conventional anti-inflammatory drugs. IL-18 appears to be the dominant cytokine driving the most dangerous complications of NLRC4-related disease, particularly macrophage activation syndrome. Blocking IL-1β alone, which works well in other inflammasome-related conditions, was not sufficient for these patients. The success of IL-18 blockade has implications beyond NLRC4 mutations, potentially informing treatment of other conditions where IL-18 levels are pathologically elevated.
NLRC4 and Colorectal Cancer
Research has positioned NLRC4 as a tumor suppressor in colorectal cancer. The proposed mechanisms are varied: NLRC4 appears to protect against colorectal cancer through pyroptosis of abnormal cells, regulation of the local immune response, and maintenance of intestinal epithelial barrier integrity.16PubMed Central. NLRC4, inflammation and colorectal cancer (Review) Its connections to multiple signaling pathways including caspase-1, IL-1β, and p53 suggest it sits at a crossroads of inflammation and cancer surveillance in the gut.
This makes intuitive sense given NLRC4’s role in expelling damaged or infected epithelial cells. A system that ejects compromised cells from the intestinal lining could plausibly also eject cells that have undergone early cancerous changes. The research is still at a relatively early stage, and most of the evidence comes from animal models and cell-culture experiments, but the convergence of NLRC4’s known functions with known colorectal cancer pathways is suggestive enough that it has attracted dedicated review attention.
Evolutionary Pressure on the Detection System
The NAIP sensor proteins that feed into NLRC4 have undergone significant evolutionary reshuffling. Mice have multiple NAIP genes, each specialized for a different bacterial target, while humans have consolidated into a single gene. Analysis of NAIP genes across mammals has shown signs of positive selection, meaning these genes have been under strong evolutionary pressure to change, likely driven by the constant arms race with bacterial pathogens.17PubMed Central. Role of positive selection in functional divergence of mammalian neuronal apoptosis inhibitor proteins during evolution Some NAIP copies in various species have become pseudogenes, nonfunctional remnants that no longer produce working protein, while others have diverged to take on new detection roles.
The practical consequence is that findings from mouse NLRC4 studies do not always translate directly to humans. A mouse with seven NAIP sensors may partition its detection differently than a human with one. This is especially relevant for drug development and for interpreting animal studies of NLRC4-related disease. The core NLRC4 protein itself is more conserved across species, but the sensor layer sitting above it has been remodeled by each lineage’s particular history of bacterial exposure.